 | Up a level |
Govaere, Olivier; Petersen, Sine Kragh; Martinez-Lopez, Nuria; Wouters, Jasper; Van Haele, Matthias; Mancina, Rosellina M; Jamialahmadi, Oveis; Bilkei-Gorzo, Orsolya; Lassen, Pierre Bel; Darlay, Rebecca; Peltier, Julien; Palmer, Jeremy M; Younes, Ramy; Tiniakos, Dina; Aithal, Guruprasad P; Allison, Michael; Vacca, Michele; Göransson, Melker; Berlinguer-Palmini, Rolando; Clark, James E; ... (2022). Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. Journal of hepatology, 76(5), pp. 1001-1012. Elsevier 10.1016/j.jhep.2021.12.012
Poitou, Christine; Puder, Lia; Dubern, Beatrice; Krabusch, Philipp; Genser, Laurent; Wiegand, Susanna; Verkindt, Hélène; Köhn, Arvid; von Schwartzenberg, Reiner Jumpertz; Flück, Christa; Pattou, François; Laville, Martine; Kühnen, Peter; Clément, Karine (2021). Long-term outcomes of bariatric surgery in patients with bi-allelic mutations in the POMC, LEPR, and MC4R genes. Surgery for obesity and related diseases, 17(8), pp. 1449-1456. Elsevier 10.1016/j.soard.2021.04.020
Clément, Karine; van den Akker, Erica; Argente, Jesús; Bahm, Allison; Chung, Wendy K; Connors, Hillori; De Waele, Kathleen; Farooqi, I Sadaf; Gonneau-Lejeune, Julie; Gordon, Gregory; Kohlsdorf, Katja; Poitou, Christine; Puder, Lia; Swain, James; Stewart, Murray; Yuan, Guojun; Wabitsch, Martin; Kühnen, Peter (2020). Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. The lancet. Diabetes & endocrinology, 8(12), pp. 960-970. Elsevier 10.1016/S2213-8587(20)30364-8
